检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:马荟[1] MA Hui(Department of Cardiovascular Medicine,Anshan Hospital First Affiliated Hospital of China Medical University, Anshan 114011, China)
机构地区:[1]中国医科大学附属第一医院鞍山医院心血管内科,114011
出 处:《中国现代药物应用》2017年第9期82-83,共2页Chinese Journal of Modern Drug Application
摘 要:目的探讨选择琥珀酸美托洛尔联合曲美他嗪治疗冠心病心力衰竭患者的临床效果。方法 102例冠心病心力衰竭患者,随机分为对照组和观察组,各51例。对照组患者给予常规治疗;在对照组治疗基础上,观察组患者给予琥珀酸美托洛尔联合曲美他嗪治疗。比较两组患者治疗效果以及左心室射血分数(LVEF)。结果观察组治疗总有效率为98.04%,高于对照组的74.51%,差异具有统计学意义(P<0.05)。治疗后为。治疗后,观察组LVEF水平为(50.15±11.38)%,高于对照组的(45.35±12.62)%,差异具有统计学意义(P<0.05)。结论对于冠心病心力衰竭患者的疾病症状表现加以明确后,除实施常规治疗之外,配合琥珀酸美托洛尔联合曲美他嗪治疗,患者心功能改善极为明显,最终获得确切的治疗效果。Objective To investigate clinical effect by metroprolol succinate combined with trimetazidinein the treatment of patients with coronary heart disease and heart failure.Methods A total of102patients withcoronary heart disease and heart failure were randomly divided into control group and observation group,with51cases in each group.The control group received conventional therapy,and the observation group receivedadditional metroprolol succinate combined with trimetazidine to therapy in the control group.Comparison wasmade on curative effect and left ventricular ejection fraction(LVEF)between the two groups.Results Theobservation group had higher total effective rate in treatment as98.04%than74.51%in the control group,andthe difference had statistical significance(P<0.05).After treatment,the observation group had higher LVEF as(50.15±11.38)%than(45.35±12.62)%in the control group,and their difference had statistical significance(P<0.05).Conclusion After definition of symptom and manifestation in patients with coronary heart disease andheart failure,implement of additional metroprolol succinate combined with trimetazidine to conventional therapyshows remarkable improvement in cardiac function,along with precisely curative effect for patients.
关 键 词:琥珀酸美托洛尔 曲美他嗪 冠心病心力衰竭 临床效果
分 类 号:R541.4[医药卫生—心血管疾病] R541.6[医药卫生—内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.80